Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 99486542 | 9948654 | 2 | F | 20130208 | 20110624 | 20140304 | 20151001 | EXP | US-ROCHE-1336300 | ROCHE | 49.87 | YR | M | Y | 0.00000 | 20151001 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 99486542 | 9948654 | 1 | PS | LUCENTIS | RANIBIZUMAB | 1 | Other | OU | 919917,881548,919917,919917,927127, | 125156 | .5 | MG | SOLUTION FOR INJECTION | /month | |||||
| 99486542 | 9948654 | 2 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | 919917,881548,919917,919917,927127, | 125156 | .3 | MG | /month | |||||||
| 99486542 | 9948654 | 3 | SS | LUCENTIS | RANIBIZUMAB | 1 | 919917,881548,919917,919917,927127, | 125156 | |||||||||||
| 99486542 | 9948654 | 4 | SS | LUCENTIS | RANIBIZUMAB | 1 | 919917,881548,919917,919917,927127, | 125156 | |||||||||||
| 99486542 | 9948654 | 5 | SS | LUCENTIS | RANIBIZUMAB | 1 | 919917,881548,919917,919917,927127, | 125156 | |||||||||||
| 99486542 | 9948654 | 6 | SS | LUCENTIS | RANIBIZUMAB | 1 | 919917,881548,919917,919917,927127, | 125156 | |||||||||||
| 99486542 | 9948654 | 7 | SS | AVASTIN | BEVACIZUMAB | 1 | Other | OS | 125085 | ||||||||||
| 99486542 | 9948654 | 8 | SS | AVASTIN | BEVACIZUMAB | 1 | 125085 | ||||||||||||
| 99486542 | 9948654 | 9 | SS | AVASTIN | BEVACIZUMAB | 1 | 125085 | ||||||||||||
| 99486542 | 9948654 | 10 | SS | AVASTIN | BEVACIZUMAB | 1 | 125085 | ||||||||||||
| 99486542 | 9948654 | 11 | SS | AVASTIN | BEVACIZUMAB | 1 | 125085 | ||||||||||||
| 99486542 | 9948654 | 12 | SS | AVASTIN | BEVACIZUMAB | 1 | 125085 | ||||||||||||
| 99486542 | 9948654 | 13 | C | LEVEMIR | INSULIN DETEMIR | 1 | Unknown | 100 UNIT/ML SOLUTION | 0 | ||||||||||
| 99486542 | 9948654 | 14 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 0 | 3.125 | MG | TABLET | ||||||||
| 99486542 | 9948654 | 15 | C | METFORMIN HYDROCHLORIDE. | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 500 | MG | |||||||||
| 99486542 | 9948654 | 16 | C | OCUFEN | FLURBIPROFEN SODIUM | 1 | Ophthalmic | 1 GTT QID IN THE OPERATIVE EYE PRN DISCOMFORT | 0 | ||||||||||
| 99486542 | 9948654 | 17 | C | ACUVAIL | KETOROLAC TROMETHAMINE | 1 | 0 | ||||||||||||
| 99486542 | 9948654 | 18 | C | BROMDAY | BROMFENAC SODIUM | 1 | Ophthalmic | 0.09% SOLN ONCE DAILY PRN FOR PAIN | 0 | ||||||||||
| 99486542 | 9948654 | 19 | C | BETADINE | POVIDONE-IODINE | 1 | Unknown | 0 | 5 | PCT | |||||||||
| 99486542 | 9948654 | 20 | C | PROPARACAINE | PROPARACAINE | 1 | 0 | ||||||||||||
| 99486542 | 9948654 | 21 | C | HUMAN INSULIN | INSULIN HUMAN | 1 | 0 | ||||||||||||
| 99486542 | 9948654 | 22 | C | CLONIDINE HCL | CLONIDINE HYDROCHLORIDE | 1 | Oral | 0 | .1 | MG | TABLET | ||||||||
| 99486542 | 9948654 | 23 | C | LOVASTATIN. | LOVASTATIN | 1 | Oral | 0 | 10 | MG | TABLET | ||||||||
| 99486542 | 9948654 | 24 | C | FLUOXETINE HCL | FLUOXETINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 99486542 | 9948654 | 1 | Retinal oedema |
| 99486542 | 9948654 | 2 | Diabetic retinopathy |
| 99486542 | 9948654 | 3 | Diabetic retinal oedema |
| 99486542 | 9948654 | 4 | Macular oedema |
| 99486542 | 9948654 | 5 | Type 1 diabetes mellitus |
| 99486542 | 9948654 | 6 | Cataract |
| 99486542 | 9948654 | 7 | Retinal oedema |
| 99486542 | 9948654 | 8 | Diabetic retinopathy |
| 99486542 | 9948654 | 9 | Diabetic retinal oedema |
| 99486542 | 9948654 | 10 | Macular oedema |
| 99486542 | 9948654 | 11 | Type 1 diabetes mellitus |
| 99486542 | 9948654 | 12 | Cataract |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 99486542 | 9948654 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 99486542 | 9948654 | Basal cell carcinoma | |
| 99486542 | 9948654 | Blindness | |
| 99486542 | 9948654 | Blood pressure abnormal | |
| 99486542 | 9948654 | Cataract | |
| 99486542 | 9948654 | Eye movement disorder | |
| 99486542 | 9948654 | Eye oedema | |
| 99486542 | 9948654 | Impaired healing | |
| 99486542 | 9948654 | Pupil fixed | |
| 99486542 | 9948654 | Vitreous haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 99486542 | 9948654 | 1 | 20110207 | 0 |